2011
DOI: 10.5761/atcs.cr.09.01482
|View full text |Cite
|
Sign up to set email alerts
|

Pleuroperitoneal Shunt for Chylothorax and Chylopericardium in Lung Cancer: A Case Report

Abstract: A 70-year-old man with T1N3M1 stage IV squamous cell carcinoma in the right upper lobe of the lung developed chylothorax and chylopericardium as rare simultaneous complications. Intravenous hyperalimentation, repeated pleurodesis, and ligation of the thoracic duct were all ineffective. A pleuroperitoneal shunt was inserted into the right pleural cavity from the fifth intercostal space, and a peritoneal catheter was placed in the abdominal cavity. Chylothorax was markedly improved, and the quality of life of th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 8 publications
0
7
0
Order By: Relevance
“…Another increasingly popular therapeutic option that might also be offered to patients with unexpandable lung is chest tube insertion to permanently drain the pleural fluid (indwelling or tunneled pleural catheter, IPC). Pleuro-peritoneal [12] or pleuro-venal [13, 14] shunts are hardly ever used anymore, because of the invasive character of the procedure and the high complication rate. With IPC, symptomatic relief can be achieved in 70–94.2% patients with MPE [15, 16].…”
Section: Background and Clinical Aspects Of Pleurodesismentioning
confidence: 99%
“…Another increasingly popular therapeutic option that might also be offered to patients with unexpandable lung is chest tube insertion to permanently drain the pleural fluid (indwelling or tunneled pleural catheter, IPC). Pleuro-peritoneal [12] or pleuro-venal [13, 14] shunts are hardly ever used anymore, because of the invasive character of the procedure and the high complication rate. With IPC, symptomatic relief can be achieved in 70–94.2% patients with MPE [15, 16].…”
Section: Background and Clinical Aspects Of Pleurodesismentioning
confidence: 99%
“…Pleurodesis has been used as an adjunct to TD ligation or in addition to fibrin glue when the site of the injury could not be identified (14). Pleuroperitoneal shunts are useful equipment in the armamentaria for managing chylothorax but are more often inserted for patients with refractory chylothorax from non-stab causes (16,17).…”
Section: Discussionmentioning
confidence: 99%
“…Chemical pleurodesis may also be considered in cases not responding to conservative therapy ( 20 , 21 ), and in refractory cases, thoracic duct ligation can be done via open thoracotomy or video-assisted thoracoscopic surgery ( 22 ). Thoracic duct embolization is also an option, but it is technically challenging ( 23 ) and lastly, for those patients who fail conservative treatment pleuroperitoneal shunt can be performed as a palliative procedure ( 24 , 25 ).…”
Section: Discussionmentioning
confidence: 99%